1. Home
  2. ATRC vs MFIC Comparison

ATRC vs MFIC Comparison

Compare ATRC & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
    SELLHOLDBUYas of 3 hours ago
  • MFIC
    SELLHOLDBUYas of 3 hours ago
  • Stock Information
  • Founded
  • ATRC 2000
  • MFIC 2004
  • Country
  • ATRC United States
  • MFIC United States
  • Employees
  • ATRC N/A
  • MFIC N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • MFIC Finance/Investors Services
  • Sector
  • ATRC Health Care
  • MFIC Finance
  • Exchange
  • ATRC Nasdaq
  • MFIC Nasdaq
  • Market Cap
  • ATRC 1.6B
  • MFIC 1.4B
  • IPO Year
  • ATRC 2005
  • MFIC 2004
  • Fundamental
  • Price
  • ATRC $30.82
  • MFIC $11.65
  • Analyst Decision
  • ATRC Strong Buy
  • MFIC Hold
  • Analyst Count
  • ATRC 10
  • MFIC 5
  • Target Price
  • ATRC $48.50
  • MFIC $14.25
  • AVG Volume (30 Days)
  • ATRC 639.5K
  • MFIC 629.3K
  • Earning Date
  • ATRC 04-30-2025
  • MFIC 05-12-2025
  • Dividend Yield
  • ATRC N/A
  • MFIC 12.10%
  • EPS Growth
  • ATRC N/A
  • MFIC N/A
  • EPS
  • ATRC N/A
  • MFIC 1.27
  • Revenue
  • ATRC $465,307,000.00
  • MFIC $301,782,000.00
  • Revenue This Year
  • ATRC $14.60
  • MFIC $16.38
  • Revenue Next Year
  • ATRC $12.58
  • MFIC $2.44
  • P/E Ratio
  • ATRC N/A
  • MFIC $10.05
  • Revenue Growth
  • ATRC 16.55
  • MFIC 9.13
  • 52 Week Low
  • ATRC $18.94
  • MFIC $12.26
  • 52 Week High
  • ATRC $43.11
  • MFIC $16.36
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 37.03
  • MFIC 23.91
  • Support Level
  • ATRC $31.02
  • MFIC $12.70
  • Resistance Level
  • ATRC $34.30
  • MFIC $13.30
  • Average True Range (ATR)
  • ATRC 1.75
  • MFIC 0.21
  • MACD
  • ATRC -0.03
  • MFIC -0.06
  • Stochastic Oscillator
  • ATRC 10.33
  • MFIC 0.43

Stock Price Comparison Chart: ATRC vs MFIC

ATRC
MFIC
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090ATRC VS MFIC

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use